Press release
Biomarkers Market Forecast to Grow at 13.3% CAGR from 2024 to 2031 | SkyQuest Technology
Biomarkers Market Size, Share, Growth Analysis, By Product & Service(Consumables (Assay Kits, Reagents & Chemicals, Columns & Filters), Services), By Type(Safety Biomarkers, Efficacy Biomarkers (Predictive Biomarkers, Surrogate Biomarkers, Pharmacodynamic Biomarkers), By Research Area(Genomics, Proteomics, Metabolomics, and Other Research Areas), By Technology(Immunoassays (ELISA, Protein Microarrays, Western Blot), NGS), By Region - Industry Forecast 2024-2031Biomarkers Market [https://www.skyquestt.com/report/biomarkers-market] size was valued at around USD 66.97 Billion in 2022 and is expected to rise from USD 75.88 Billion in 2023 to reach a value of USD 206.04 Billion by 2031, at a CAGR of 13.3% over the forecast period (2024-2031).
Healthcare professionals see biomarkers as an extremely useful tools that can be used in medical research, diagnostics, and personalized medicine. These tools offer information about a person's health enabling early detection and diagnosis. In the past few years, there has been an increase in chronic diseases among people mainly due to lifestyle changes. This is one of the primary reasons for the growth of the biomarkers market. The use of biomarkers in diagnosis of infectious diseases is also becoming very common rapidly. For example, a MicroRNA-based biomarker is being used for the diagnosis of infectious viruses like rhinovirus, HIV, malaria, Hendra, influenza, Ebola, and malaria. Biomarkers which were under study during the SARS-CoV-2 have a high prognostic potential. It played a critical role in the asymptomatic cases that was creating issues while tracking the pandemic cases. These biomarkers also have extremely high stability power even though they are in a freeze and thaw cycles, giving them added benefits. Drug development organizations are continuously introducing advanced treatments that combines biomarkers along with new or current medicines. Today, it is possible to use biomarkers for the treatment of neurological issues as it can monitor brain health by measuring molecules.
Download a detailed overview:
https://www.skyquestt.com/sample-request/biomarkers-market
Advancement of Biomarkers Driven by Rising Focus on Personalized Medications
Innovative diagnostics tools for early detection of illnesses have become a necessity due to the increasing cases of chronic diseases. Biomarkers plays an important part as they have the ability to recognize and monitor diseases on a molecular level. Today, new biomarker is also experiencing advancement in the omics platforms of genomics and proteomics, helping in the enhancement of diagnosis. With the development in these platforms, it has become possible to sequence entire genomes or a unique section with the help of highly advanced methods such as next-generation sequencing. It has also made gene sequencing faster and affordable. Moreover, the increasing emphasis on personalized medicine and precise therapeutic methods are also influencing the demand for advanced biomarkers. This therapy is useful for offering the right treatment to the patient, with an accurate dose, and at the right time.
Increasing Cases of Cancer to Drive the Biomarker Market Growth
Biomarkers are important for fighting against the increasing incidences of cancer by allowing early identification, precise diagnosis, selection treatment, and monitoring the growth of the disease. This therapy can be utilized for screening and detecting cancer at an early stage, so that medical providers can start the treatment when it is curable. Two common examples of biomarker-powered screening methods are blood tests and liquid biopsies. These can track the presence of a particular biomarker connected to a unique malignancy. Biomarkers also have the ability to forecast the possibly a patient will react to the therapy. It will become medical professionals to recognize the patients who can actually benefit from a particular method like targeted medicines or immunotherapies by evaluating biomarkers.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/biomarkers-market
* In March 2024, Alamar Biosciences publicized the commercial launch of their ultra-high sensitive NULISAseq CNS disease panel 120 and NULISAqpcr PTau-217 assays.
* In October 2023, Summa Equity got counsel from Ropes & Gray in the sale to Thermo Fisher Scientific Inc.
* Labcorp introduced their tri-biomarker blood test in October 2023. It can diagnose Alzheimer's disease.
* In February 2024, Abbott Laboratories and Fujireblio collaborated to produce a research uses only neurofilament-light chain neurology biomarker assay.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/biomarkers-market
Massive Growth in the Biomarkers Market with Implementation of Advanced Technologies
In recent times, the biomarkers market has seen immense growth due to the advancement in personalized medicine, diagnostic technologies, and better understanding of molecular biology. Biomarkers plays an important role in changing the patient care by providing exact and early signs of diseases, its progress, and treatment response. The implementation of advanced technologies like genomic, proteomics, and metabolomics have extended the opportunities of the biomarkers market in different therapeutic region, starting from oncology to neurology.
Related Reports:
Augmented, Virtual and Mixed Reality Market [https://www.skyquestt.com/report/ar-vr-mr-market]
Visit Our Website: https://www.skyquestt.com/
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=biomarkers-market-forecast-to-grow-at-133-cagr-from-2024-to-2031-skyquest-technology]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/biomarkers-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Market Forecast to Grow at 13.3% CAGR from 2024 to 2031 | SkyQuest Technology here
News-ID: 3597325 • Views: …
More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg
Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject.
Essential Platform Features for Effective Online Chemistry Tutoring
Modern chemistry tutoring…

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…

Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by…

Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…